Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Kerff

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Journal of Antimicrobial Chemotherapy|July 14, 2010
Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamasesMaría Merino, Francisco J Pérez-Llarena, Frederic Kerff, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2023
Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-LactamasesFrédéric Cawez, Paola Sandra Mercuri, Francisco Javier Morales-Yãnez, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Journal of Antimicrobial Chemotherapy|July 14, 2010
Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamasesMaría Merino, Francisco J Pérez-Llarena, Frederic Kerff, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2023
Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-LactamasesFrédéric Cawez, Paola Sandra Mercuri, Francisco Javier Morales-Yãnez, et al.
Pageof 2